Physician profile
David P Russo
NPI 1588647143
$1,293.49
in general payments reported to CMS, 2019-2025
5 companies · $1,091 in 2025
The $1,091 reported for 2025 was more than what 89% of Addiction Medicine (Internal Medicine) providers received nationally (typical 2025 total: $124).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14.51 · 2022: $11.77 · 2023: $16.65 · 2024: $159 · 2025: $1,091.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,020 · Food and Beverage: $248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,019.55 |
| Food and Beverage | $247.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,215.23 | 2024-2025 | Proclaim |
| Alkermes, INC. | $31.16 | 2020-2023 | Vivitrol |
| Bioventus LLC | $19.00 | 2024 | Durolane |
| Indivior INC. | $16.33 | 2025 | Sublocade |
| Astrazeneca Pharmaceuticals LP | $11.77 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Russo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.